510(k) device
Veloxion System
Corinth Medtech, Inc. · Resectoscope (FJL, Class II) · First FDA decision Mar 24, 2017, newest Feb 24, 2023Bladder cancerEnlarged prostate (BPH)
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
1
Naming "Veloxion"
MAUDE reports
0
Brand "Veloxion", since 2015
PubMed studies
0
Mentioning "Veloxion"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Veloxion System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Veloxion System510(k)
K230205 · Decided Feb 24, 2023 · 30 days after receipt
Device type: Resectoscope (FJL) · GI, Urology & Nephrology
- Veloxion System510(k)
K162979 · Decided Mar 24, 2017 · 149 days after receipt
Device type: Resectoscope (FJL) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Veloxion", any status and sponsor, newest update first.
Chinese University of Hong KongAcademic, hospital or other
NCT07728071 · 20 participants (planned) · Start Oct 2, 2026 · Primary completion Jun 30, 2027
Device: Aulea Veloxion™ Disposable Resectoscope System · For: BPH (Benign Prostatic Hyperplasia)
Sites: Shatin, Hong Kong
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Veloxion", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code FJL
638 reports: 482 malfunction, 147 injury, 3 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Veloxion"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code FJL.
- Veloxion Controller KitCorinth Medtech, Inc. · 510(k) 2019
- Cysto-Urethroscopes and accessoriesHangzhou Hawk Optical Electronic Instruments Co., Ltd. · 510(k) 2026
- KARL STORZ Monopolar Resectoscopes with HF CableKarl Storz SE & CO. KG · 510(k) 2024
- KARL STORZ Bipolar Resectoscopes with HF CableKarl Storz Endoscopy America, Inc. · 510(k) 2023
- Aed ResectoscopeNational Advanced Endoscopy Devices, Inc. · 510(k) 2010
- S-Line Bipolar Resectoscopes and Bipolar ElectrodesRichard Wolf Medical Instruments Corp. · 510(k) 2007
- Resection PumpRichard Wolf Medical Instruments Corp. · 510(k) 2005
- Morce Scope Set 8970 with Power Control 2303 and Suction Pump 2207Richard Wolf Medical Instruments Corp. · 510(k) 2004
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.